In vivo delivery of nucleic acids via glycopolymer vehicles affords therapeutic infarct size reduction in vivo. [electronic resource]
Producer: 20120709Description: 601-8 p. digitalISSN:- 1525-0024
- Animals
- Cell Line
- Cells, Cultured
- Drug Delivery Systems
- Gene Expression
- Gene Silencing
- Gene Transfer Techniques
- Heart Ventricles -- metabolism
- Mice
- Mice, Inbred C57BL
- Myoblasts, Cardiac -- metabolism
- Myocardial Reperfusion Injury -- genetics
- Myocytes, Cardiac -- metabolism
- NF-kappa B -- antagonists & inhibitors
- Nanoconjugates -- therapeutic use
- Oligodeoxyribonucleotides -- chemistry
- Polymers -- chemistry
- Rats
- Rats, Wistar
- Transduction, Genetic
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.